HER2 Support Group Forums - View Single Post

Lani · 12-17-2007, 04:30 PM

Treatment: Male Breast Cancer
5048 Male breast cancer (MBC): impact of early diagnosis and adjuvant treatments. Analysis of 983 cases.
Cutuli B, Cohen-Solal-Le-Nir C, Serin D, Kirova Y, Belkacemi Y, Gaci Z, Lemanski C, De Lafontan B, Zoubir M, Maingon P, Mignotte H, Tunon de Lara C, Edeline J, Penault-Llorca F, Romestaing P, Delva C. Polyclinique de Courlancy, Reims, France; Sylia-Stat, Bourg La Reine, France.
5049 Survivin and COX-2 expression in male breast cancer.
Younis T, Dakin-Hache KA, Rayson D, Dewar R, Gray S, Barnes PJ. Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada; Cancer Care Nova Scotia, Halifax, NS, Canada; Dalhousie Medical School, Halifax, NS, Canada.
5050 Patterns of body size in male breast cancer and impact of obesity on disease outcome.
Kulkarni S, Franssen E, Madarnas Y. Queen's University, Kingston, ON, Canada.
5051 Expression of basal-like markers in male breast cancers.
Flanagan MB, Bhargava R, Dabbs DJ, Thull D, Chivukula M. Magee-Womens Hospital, Pittsburgh, PA.

will try to bring you highlights later.

Obviously the last one doesn't apply as it is triple negative.

More later...

12-17-2007, 04:30 PM	#4
Lani Senior Member Join Date: Mar 2006 Posts: 4,778	list of posters on male breast cancer Treatment: Male Breast Cancer 5048 Male breast cancer (MBC): impact of early diagnosis and adjuvant treatments. Analysis of 983 cases. Cutuli B, Cohen-Solal-Le-Nir C, Serin D, Kirova Y, Belkacemi Y, Gaci Z, Lemanski C, De Lafontan B, Zoubir M, Maingon P, Mignotte H, Tunon de Lara C, Edeline J, Penault-Llorca F, Romestaing P, Delva C. Polyclinique de Courlancy, Reims, France; Sylia-Stat, Bourg La Reine, France. 5049 Survivin and COX-2 expression in male breast cancer. Younis T, Dakin-Hache KA, Rayson D, Dewar R, Gray S, Barnes PJ. Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada; Cancer Care Nova Scotia, Halifax, NS, Canada; Dalhousie Medical School, Halifax, NS, Canada. 5050 Patterns of body size in male breast cancer and impact of obesity on disease outcome. Kulkarni S, Franssen E, Madarnas Y. Queen's University, Kingston, ON, Canada. 5051 Expression of basal-like markers in male breast cancers. Flanagan MB, Bhargava R, Dabbs DJ, Thull D, Chivukula M. Magee-Womens Hospital, Pittsburgh, PA. will try to bring you highlights later. Obviously the last one doesn't apply as it is triple negative. More later...